157 related articles for article (PubMed ID: 9613746)
1. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
Pranzatelli MR; Huang YY; Tate E; Goldstein DS; Holmes CS; Goldstein EM; Ketner K; Kinast M; Lange BM; Sanz A; Shevell MI; Stanford RE; Taff IP
Mov Disord; 1998 May; 13(3):522-8. PubMed ID: 9613746
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
[TBL] [Abstract][Full Text] [Related]
3. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
5. Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia.
Assmann B; Köhler M; Hoffmann GF; Heales S; Surtees R
Pediatr Res; 2002 Jul; 52(1):91-4. PubMed ID: 12084853
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
Langlais PJ; Walsh FX; Bird ED; Levy HL
Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
Pranzatelli MR; Chun KY; Moxness M; Tate ED; Allison TJ
Pediatr Neurol; 2005 Aug; 33(2):121-6. PubMed ID: 16087057
[TBL] [Abstract][Full Text] [Related]
8. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
9. [Reduced sympathetic nervous system activity during the cluster period of cluster-headache].
Strittmatter M; Hamann GF; Blaes F; Grauer M; Fischer C; Hoffmann KH
Schweiz Med Wochenschr; 1996 Jun; 126(24):1054-61. PubMed ID: 8701243
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Hoefgen ER; Swan JA; Colliver JA
Cytokine; 2008 Oct; 44(1):26-32. PubMed ID: 18675552
[TBL] [Abstract][Full Text] [Related]
12. CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsive.
Pranzatelli MR; Tate ED; McGee NR; Ransohoff RM
Cytokine; 2013 Oct; 64(1):331-6. PubMed ID: 23764550
[TBL] [Abstract][Full Text] [Related]
13. A study of CSF catecholamine and its metabolites in acute and convalescent period of encephalitis.
Kalita J; Kumar S; Vijaykumar K; Palit G; Misra UK
J Neurol Sci; 2007 Jan; 252(1):62-6. PubMed ID: 17134724
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.
Hyland K; Surtees RA; Heales SJ; Bowron A; Howells DW; Smith I
Pediatr Res; 1993 Jul; 34(1):10-4. PubMed ID: 7689195
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to ACTH in opsoclonus-myoclonus.
Pranzatelli MR; Kao PC; Tate ED; Chaves E; Chez M; Dobyns WB; Kang H; Rothner DA
Neuropediatrics; 1993 Jun; 24(3):131-3. PubMed ID: 8395029
[TBL] [Abstract][Full Text] [Related]
16. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
Zeman J; Böswart J
Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
Mitani H; Shirayama Y; Yamada T; Kawahara R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
[TBL] [Abstract][Full Text] [Related]
18. A rostrocaudal gradient for neurotransmitter metabolites and a caudorostral gradient for protein in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Whitmer B; Satjawatcharaphong C
Am J Vet Res; 1988 Dec; 49(12):2134-7. PubMed ID: 2467594
[TBL] [Abstract][Full Text] [Related]
19. The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment.
Airaksinen E; Tuomisto L; Riikonen R
Brain Dev; 1992 Nov; 14(6):386-90. PubMed ID: 1283505
[TBL] [Abstract][Full Text] [Related]
20. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
